We are live on ! Find out more
ACM

Argyle Capital Management Portfolio holdings

AUM $347M
1-Year Est. Return 44.33%
This Fund
S&P 500
This Quarter Est. Return
-2.8%
1 Year Est. Return
+44.33%
3 Year Est. Return
+95.77%
5 Year Est. Return
+124.66%
10 Year Est. Return
+325.03%
AUM
$254M
AUM Growth
+$2.65M
Cap. Flow
+$13.1M
Cap. Flow %
5.18%
Top 10 Hldgs %
26.44%
Holding
129
New
5
Increased
82
Reduced
14
Closed
2

Top Buys

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$934K
2
NXPI icon
NXP Semiconductors
NXPI
+$920K
3
TXN icon
Texas Instruments
TXN
+$674K
4
DELL icon
Dell
DELL
+$617K
5
CB icon
Chubb
CB
+$583K

Sector Composition

Rank Sector Weight
1 Technology 20.34%
2 Healthcare 19.62%
3 Financials 13.83%
4 Industrials 13.25%
5 Energy 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWL icon
126
Newell Brands
NWL
$2.38B
$116K 0.05%
11,600
-1,900
-14% -$17.2K
WBD icon
127
Warner Bros
WBD
$65.9B
$108K 0.04%
10,235
-1,202
-11% -$11.2K
OSUR icon
128
OraSure Technologies
OSUR
$279M
-10,025
Closed -$42.8K
VTRS icon
129
Viatris
VTRS
$20.4B
-10,217
Closed -$119K

Similar funds

Argyle Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Argyle Capital Management held 129 positions worth $254M, up 1.1% from $251M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Argyle Capital Management deployed $13.1M of net new capital in Q4 2024, opening 5 new positions and adding to 82 existing holdings. Its largest new stake was Global Payments: 8,537 shares worth $957K.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was CVS Health, an estimated $285K trimmed.

  • Argyle Capital Management's largest Q4 2024 buy was Global Payments: 8,537 shares worth $957K.
  • Argyle Capital Management added most to Dell in Q4 2024, an estimated $617K increase.
  • Argyle Capital Management's biggest Q4 2024 reduction was CVS Health, cutting an estimated $285K.
  • Argyle Capital Management fully exited Viatris in Q4 2024, selling an estimated $119K.
  • Argyle Capital Management's ten largest holdings make up 26% of its $254M portfolio in Q4 2024.
  • Argyle Capital Management opened 5 new positions and closed 2 in Q4 2024.
  • Argyle Capital Management's portfolio value rose 1.1% quarter-over-quarter to $254M.

Based on Argyle Capital Management's 13F filing for Q4 2024, filed 5 Feb 2025.